Showing results (151-160 of 384) with videos related to
Sort By:
Pageof 39
Transplant International : Official Journal of the European Society for Organ Transplantation|August 1, 1994
The use of plasma levels for FK 506 dosing in liver-grafted patientsM Winkler, B Ringe, B Rodeck, et al.Zentralblatt Fur Chirurgie|April 29, 1998
[Diagnostic and therapeutic strategies in hepatocellular adenoma]A Weimann, K Fronhoff, K F Gratz, et al.European Journal of Clinical Investigation|July 1, 1995
Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant periodV W Armstrong, E Schütz, M Kaltefleiter, et al.The Japanese Journal of Surgery|November 1, 1985
Developments in liver transplantationR Pichlmayr, P Neuhaus, B Ringe, et al.Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Refractory hydrothorax in primary biliary cirrhosis: successful treatment with transjugular intrahepatic portosystemic stent shunt]W Nolte, H R Figulla, B Ringe, et al.Journal of Bacteriology|November 5, 2003
Flavobacterium johnsoniae GldH is a lipoprotein that is required for gliding motility and chitin utilizationMark J McBride, Timothy F Braun, Jessica L BrustRadiology|May 1, 1983
Spinal cord imaging using real-time high-resolution ultrasoundI F Braun, B N Raghavendra, I I KricheffLangenbecks Archiv Fur Chirurgie|January 1, 1991
[In situ protection of the liver with Bretschneider HTK solution]P Lamesch, S Raygrotzki, G Kehrer, et al.Therapeutic Drug Monitoring|October 1, 1995
Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipientsU Christians, K Kohlhaw, T Sürig, et al.Transplantation|February 27, 1996
Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patientsB Nashan, H J Schlitt, R Schwinzer, et al.Pageof 39